Marc Cobo reports tax withholding on shares at BBOT
By AlphaYouPublished Form 4
Cobo Marc
Reporting filer
Marc Cobo reports tax withholding on shares, not an open-market purchase or sale, in BridgeBio Oncology Therapeutics, Inc.. Form 4 filed Oct 23, 2026 lists 1 entry.
- Disclosed
- Oct 23, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Cobo Marc | 2026-10-21 | F | Tax/exercise withholding | 203 | 2.68 | 13,812 | 2 days | Filed terms
|
Common Stock
- Owner
- Cobo Marc
- Date
- 2026-10-21
- Code
- F
- Action
- Tax/exercise withholding
- Quantity
- 203
- Price
- 2.68
- Following holdings
- 13,812
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-21
- transaction Form Type: 4
- transaction Code: F
- equity Swap Involved: false
- transaction Shares: 203
- id: F1
- transaction Price Per Share: 2.68
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 13812
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Cobo Marc: Principal Accounting Officer.
- F1: Represents the number of shares of the Issuer's Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.
Original sources
Prepared automatically from public filing data. Report a correction.